Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/20/2025

COVID-19 Management in Adrenal Insufficiency Patients

Introduction to Corticosteroid Therapy

  • The European Respiratory Society recommends that dexamethasone should not be given to COVID-19 patients without oxygen requirement, as the RECOVERY trial showed potential harm (mortality 17.0% vs 13.2%, RR=1.22) 1
  • Patients with adrenal insufficiency must maintain adequate glucocorticoid replacement at all times to avoid adrenal crisis, with a strength of evidence supporting the importance of continuous glucocorticoid replacement 3

Corticosteroid Administration

  • Do NOT add dexamethasone for COVID-19 treatment in patients not requiring oxygen, as it provides no benefit and may cause harm, according to the American College of Physicians 1, 2
  • Add dexamethasone 6 mg once daily for up to 10 days once oxygen requirement is established (SpO2 <94% on room air), as recommended by the American Thoracic Society 1, 2
  • The stress-dose hydrocortisone covers adrenal insufficiency; dexamethasone addresses COVID-19 inflammatory response, with a moderate strength of evidence supporting this distinction 2

Monitoring and Prevention

  • Daily oxygen saturation monitoring is recommended for all COVID-19 positive patients with adrenal insufficiency, according to the European Respiratory Society 1
  • Patients with adrenal insufficiency face increased infection risk, but current evidence does not suggest they develop more severe COVID-19 than the general population, with a low strength of evidence supporting this claim 3

REFERENCES

1

Steroid Use in Non-Severe COVID-19 Patients on Dialysis Receiving Molnupiravir [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Dexamethasone and Remdesivir Dosing for Severe COVID-19 [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025